GILD - Company ID 0000882095
GILEAD SCIENCES, INC. (GILD) reported net income of $8.51B for fiscal year 2025, as filed in its audited annual report with the SEC.
| Fiscal year | Net Income | Change |
|---|---|---|
| FY 2025 | $8.51B | +1672.9% |
| FY 2024 | $480.00M | -91.5% |
| FY 2023 | $5.67B | +23.4% |
| FY 2022 | $4.59B | -26.2% |
| FY 2021 | $6.22B | +4961.0% |
| FY 2020 | $123.00M | -97.7% |
| FY 2019 | $5.39B | -1.3% |
| FY 2018 | $5.46B | +17.9% |
| FY 2017 |
GILEAD SCIENCES, INC. (GILD) reported net income of $8.51B for fiscal year 2025, as filed in its audited annual report with the SEC.
Between fiscal 2011 and fiscal 2025, GILEAD SCIENCES, INC.'s net income grew from $2.80B to $8.51B.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| $4.63B |
| -65.7% |
| FY 2016 | $13.50B | -25.4% |
| FY 2015 | $18.11B | +49.6% |
| FY 2014 | $12.10B | +293.5% |
| FY 2013 | $3.08B | +18.6% |
| FY 2012 | $2.59B | -7.5% |
| FY 2011 | $2.80B | - |